 Clinical doxorubicin chemomyectomy experimental treatment benign essential blepharospasm hemifacial spasm Doxorubicin DXR treatment benign essential blepharospasm hemifacial spasm eyelids botulinum toxin BT DXR-treated eyelid strength BT patients benign essential blepharospasm patients hemifacial spasm major improvement months Eyelids months irreversible complication single injection maximum safe dose mg upper lid mg lid sufficient cure Treatment eyelid muscular male severe blepharospasm cumulative doses mg injection events months injection mg DXR site present time assurance permanent cure